Role of renin-angiotensin system in adipose tissue dysfunction (Q37466234)

20 August 2017

1 reference

title

Role of renin-angiotensin system in adipose tissue dysfunction (English)

1 reference

20 August 2017

Masaru Iwai

1

1 reference

PubMed ID

19407825

20 August 2017

Masatsugu Horiuchi

series ordinal

2

1 reference

20 August 2017

1 May 2009

1 reference

20 August 2017

Hypertension Research

1 reference

20 August 2017

32

1 reference

20 August 2017

6

1 reference

20 August 2017

425-427

1 reference

https://scigraph.springernature.com/pub.10.1038/hr.2009.55

20 August 2017

0 references

cites work

Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.55

Angiotensin II type-1 receptor blocker valsartan enhances insulin sensitivity in skeletal muscles of diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.55

Angiotensin II-induced skeletal muscle insulin resistance mediated by NF-kappaB activation via NADPH oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.55

Improvement of insulin sensitivity by antagonism of the renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.55

Insulin signalling, exercise and cellular integrity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.55

Angiotensin II: a major regulator of subcutaneous adipose tissue blood flow in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.55

Review: Peroxisome proliferator-activated receptor gamma and adipose tissue--understanding obesity-related changes in regulation of lipid and glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.55

Expression of angiotensin II receptors type 1 and type 2 in human preadipose cells during differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.55

Deletion of the angiotensin type 2 receptor (AT2R) reduces adipose cell size and protects from diet-induced obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.55

Blockade of AT1 receptor improves adipocyte differentiation in atherosclerotic and diabetic models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.55

Sympathetic modulation by carvedilol and losartan reduces angiotensin II-mediated lipolysis in subcutaneous and visceral fat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.55

Mice lacking angiotensin-converting enzyme have increased energy expenditure, with reduced fat mass and improved glucose clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.55

Angiotensin blockade prevents type 2 diabetes by formation of fat cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.55

Nuclear receptors as targets for drug development: molecular mechanisms for regulation of obesity and insulin resistance by peroxisome proliferator-activated receptor gamma, CREB-binding protein, and adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.55

Local renin angiotensin expression regulates human mesenchymal stem cell differentiation to adipocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.55

Blockade of the renin-angiotensin system decreases adipocyte size with improvement in insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.55

Adiponectin and adiponectin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.55

Prevention of adipose tissue depletion during food deprivation in angiotensin type 2 receptor-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.55

Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.55

Theodore Cooper Lecture: Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.55

Angiotensin II-mediated development of vascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.55

Angiotensin II type 2 receptor stimulation: a novel option of therapeutic interference with the renin-angiotensin system in myocardial infarction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.55

TAK-536, a new AT1 receptor blocker, improves glucose intolerance and adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.55

7 January 2021

Beneficial effects of candesartan, an angiotensin II type 1 receptor blocker, on beta-cell function and morphology in db/db mice

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.55

7 January 2021

Adipose tissue as an endocrine organ

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.55

7 January 2021

Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.55

7 January 2021

AT2 receptor deficiency attenuates adipocyte differentiation and decreases adipocyte number in atherosclerotic mice.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.55

7 January 2021

Inhibiting angiotensin type 1 receptors as a target for diabetes

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.55

7 January 2021

Identifiers

DOI

10.1038/HR.2009.55

1 reference

PubMed ID

19407825

Dimensions Publication ID

20 August 2017

0 references

1 reference

PubMed ID

19407825